Backgrounds/Aims: In hepatocellular carcinoma (HCC), bile duct invasion occurs far more rarely than vascular invasion and is not well characterized. In addition, the pathologic finding of bile duct invasion is not considered an independent prognostic factor for HCC following surgery. In this study, we determined the characteristics of HCC with bile duct invasion, and assessed the clinical significance of bile duct invasion. Methods: We retrospectively reviewed the medical records of 363 patients who underwent hepatic resection for HCC at Seoul National University Hospital (SNUH) from January 2009 to December 2011. Preoperative, operative, and pathological data were collected. The risk factors for recurrence and survival were analyzed. Subsequently, the patients were divided into 2 groups according to disease stage (American Joint Committee on Cancer/International Union Against Cancer 7 th edition): early stage (T1 and 2) and advanced stage (T3 and 4) group; and risk factors in the sub-groups were analyzed. Results: Among 363 patients, 13 showed bile duct invasion on pathology. Patients with bile duct invasion had higher preoperative total bilirubin levels, greater microvascular invasion, and a higher death rate than those without bile duct invasion. In multivariate analysis, bile duct invasion was not an independent prognostic factor for survival for the entire cohort, but, was an independent prognostic factor for early stage. Conclusions: Bile duct invasion accompanied microvascular invasion in most cases, and could be used as an independent prognostic factor for survival especially in early stage HCC (T1 and T2). 
INTRODUCTION
Hepatocellular carcinoma (HCC), is an aggressive cancer that frequently develops as a result of chronic liver disease or cirrhosis. HCC invasion progresses from the vascular system to the bile duct. 1 Because of its complex pathophysiology and treatment, there are several staging systems and treatment strategies for HCC. However, no globally standardized staging system has yet been established. Currently, the most commonly used prognostic factors are vascular invasion, intrahepatic metastasis, tumor size and number, preoperative tumor marker levels, ascites, portal vein tumor thrombosis, and hepatitis B viral (HBV)-DNA status. 2 Bile duct invasion is not considered a prognostic factor currently. HCC with bile duct invasion, previously known as icteric HCC, is much rarer than HCC with vascular invasion and is not well characterized. 3 Several studies since 1982 have investigated the characteristics of HCC with bile duct invasion and patient prognosis. 3 However, the prognosis of these patients remains controversial. 3 Furthermore, bile duct invasion has not been included in the HCC staging system. 2 Herein, we investigated the characteristics of HCC with bile duct invasion in relation to cases of the disease without such invasion, in order to elucidate the clinical significance of bile duct invasion in terms of survival following surgical resection. were estimated using the Cox proportional-hazard methodology, and estimates were reported as HR (95% confidence interval). Kaplan-Meier product-limit methodology was used to compare survival estimates between matched data sets (with and without bile duct invasion),
MATERIALS AND METHODS

Patient and clinical information
and an unadjusted comparison of survival was performed using the log-rank test. All statistical analyses were performed using SPSS 18 for Windows (Chicago, IL), and p-values＜0.05 were considered statistically significant.
RESULTS
Differences in clinical characteristics between HCC patient groups with or without bile duct invasion
The mean age of the HCC patients was 56±8.03 years, and the male-to-female ratio was approximately 4 to 1.
The maximum tumor size was 5.6±3.23 cm in diameter.
During the mean follow-up period of 3.5 years (2-58 months), disease recurrence occurred in 260 of 363 patients and 71 patients died. Table 1 showed the comparative clinical characteristics of patients with and without bile duct invasion. There were no significant differences in age, sex, etiology, preoperative AFP and PIVK-II level, pathologic tumor size, T-stage, histological grade, or recurrence rate between the 2 groups. However, 85% of patients with bile duct invasion developed microvascular invasion, as compared to 43% of patients without bile duct invasion (p=0.04). In addition, the patients with bile duct invasion had higher total bilirubin levels (p=0.04). The 6 patients without bile duct invasion showed a total bilirubin level ＞4 mg/dl, with relatively huge masses compressing the bile ducts.
Elevated levels of bilirubin were attributed to mass effect.
All 13 patients with bile duct invasion showed disease recurrence and 6 of these patients (46.2%) died. Among these 13 patients, bile duct invasion was diagnosed preoperatively in 10 patients and detected incidentally in the other 3 patients. In the patient group with bile duct invasion, the levels of bile duct tumor thrombi were as follows: common hepatic duct to the first confluence, 5 cas- 
Risk factors influencing disease recurrence and patient survival
In multivariate analysis, microvascular invasion was identified as a risk factor for recurrence (p=0.01, Table   2 ). In addition, preoperative AFP (p＜0.01), PIVKA-II level (p=0.02), microvascular invasion (p＜0.01), and pathologic tumor number (p=0.03) were identified as factors influencing patient survival (Table 3) .
In subgroup analysis according to disease stage, microvascular invasion was identified as a risk factor for recurrence in early stage HCC (p＜0.01, Table 4 ). However, for overall survival, bile duct invasion (p＜0.01), together with preoperative AFP (p=0.02), microvascular invasion (p＜0.01), and tumor number (p=0.03, Table 5 ) were significant risk factors. Bile duct invasion was not an independent risk factor for recurrence-free survival and duct invasion. 9 However, in that study, jaundice was defined as both, due to hepatic insufficiency as well as obstructive jaundice. Satoh et al. 5 and Shiomi et al. 6 also reported that prognosis of HCC with bile duct invasion is similar to that of patients without bile duct thrombus.
Furthermore, recent studies have shown that, a poor prognosis can be overcome by early detection 10 or adequate biliary drainage 13 and curative resection. 1, [4] [5] [6] [14] [15] [16] However, most of these previous studies supported the hypothesis that the prognosis of HCC with bile duct invasion can be worse than HCC without invasion, 3, 8, 9, 11, 12, 17 which was in agreement with our results.
Until recently, bile duct invasion was not considered a staging factor for HCC in the pathological TNM staging system of AJCC/UICC. 2 This is likely due to both, a small number of patients and the lack of a clear characterization of patients with bile duct invasion in the previous studies.
We investigated whether bile duct invasion can be used as an independent risk factor for determining patient survival. The results of our analyses indicated that bile duct invasion was not a significant risk factor influencing survival in all HCC patients following hepatic resection, but only for those with early stage disease. Thus, bile duct invasion can be considered an independent factor for HCC staging, especially in early stage disease.
Previous studies have suggested a number of potential reasons for the poor prognosis of HCC patients with bile duct invasion. 1, 3, 4, 7, 9, 13, 18 The first hypothesis proposes, that the infiltrative nature of HCC with bile duct invasion influences the prognosis. 1, 3, 4 However, in the present study, of the 13 patients with bile duct invasion, only 2 showed infiltrative HCC. Therefore, we concluded that the infiltrative nature of the disease was not the reason for the poor prognosis of these patients.
A second hypothesis, suggests that poor prognosis for HCC with bile duct invasion could be due to obstructive jaundice related to hepatic dysfunction. 6, 7, 9, 13, 18 However, Shiomi et al. 6 and Xiangji et al. 13 reported that prognosis The third hypothesis best explains the results of the current study. However, the limitation of this study was the relatively small patient cohort. Due to the rarity of HCC patients with bile duct invasion, further studies such as multicenter trials are required to confirm our findings.
In conclusion, the results indicated that bile duct invasion accompanied vascular invasion in most cases of HCC included in the study. HCC with bile duct invasion could be an indicator of undetected microvascular invasion. Furthermore, in early stage HCC, bile duct invasion can be used as an independent prognostic factor for survival.
